官方服务：
资源简介：
EBV-associated epithelial cancer therapy
应用场景：
创建时间：
2023-08-21
相关数据集
Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway
Epstein-Barr virus (EBV) nuclear oncoprotein EBNA3C is essential for B-cell transformation and development of several B-cell lymphomas particularly those are generated in an immuno-compromised backgro
NIAID Data Ecosystem50
A Small Molecule that Selectively Inhibits the Growth of Epstein-Barr Virus-latently Infected Cancer Cells
Raw data files, related to Figure 1, 2, 3, 4, 5, 6, 7, 8, S1, S2 and S3 published in iScience (2024）, https://doi.org/10.1016/j.isci.2024.110581.
Mendeley Data10
A metabolic dependency of EBV can be targeted to hinder B cell transformation
Following infection of B cells, Epstein Barr virus (EBV) engages host pathways that mediate cell proliferation and transformation, contributing to the propensity of the virus to drive immune dysregula
NIAID Data Ecosystem10
DataSheet_1_GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies.docx
IntroductionEpstein-Barr virus (EBV) is a widely spread pathogen associated with lymphoproliferative diseases, B/ T/ NK cell lymphomas, nasopharyngeal carcinoma (NPC) and gastric carcinoma (GC). EBV l
NIAID Data Ecosystem20
Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells
BackgroundEpstein Barr virus-associated lymphoproliferative disease is an increasing complication in patients with immunosuppressive conditions. Although the current therapies for this disorder are ef
Figshare2016-01-19 更新10
